Analysis of SARS-CoV-2 omicron mutations that emerged during long-term replication in a lung cancer xenograft mouse model-Reference-Cited by-同舟云学术

Analysis of SARS-CoV-2 omicron mutations that emerged during long-term replication in a lung cancer xenograft mouse model

Published:2024-04-08 Issue:3 Volume:60 Page:251-262
ISSN:0920-8569
Container-title:Virus Genes
language:en
Short-container-title:Virus Genes

Author:

Baek Kyeongbin,Kim Dongbum,Kim Jinsoo,Kang Bo Min,Park Heedo,Park Sangkyu,Shin Ha-Eun,Lee Myeong-Heon,Maharjan Sony,Kim Minyoung,Kim Suyeon,Park Man-Seong,Lee Younghee,Kwon Hyung-Joo

Funder

National Research Foundation of Korea

Korea Health Industry Development Institute

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11262-024-02067-6.pdf

Reference32 articles.

1. 1. Arora P, Zhang L, Rocha C, Sidarovich A, Kempf A, Schulz S et al (2022) Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3. Lancet Infect Dis 22: 766–767. https://doi:10.1016/S1473-3099(22)00224-9

2. 2. Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL et al (2022) Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 603: 679–686. https://doi:10.1038/s41586-022-04411-y

3. 3. Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N et al (2022) Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet 399: 1303–1312. https://doi:10.1016/S0140-6736(22)00462-7

4. 4. Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ et al (2022) Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science 376: eabn4947. https://doi:10.1126/science.abn4947

5. 5. Miller J, Hachmann NP, Collier AY, Lasrado N, Mazurek CR, Patio RC et al (2023) Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1. N Engl J Med 388: 662–664. https://doi:10.1056/NEJMc2214314